# DESCRIPTION

- introduce oncolytic viruses
- describe Myxoma virus
- discuss oncolytic activity of Myxoma virus
- summarize previous research on Myxoma virus
- describe SG33 strain
- compare SG33 strain with Lausanne strain
- discuss attenuated Myxoma virus as oncolytic medicament
- describe optional modifications to attenuated Myxoma virus
- outline potential uses of attenuated Myxoma virus

## Example 1

### Comparison of the Efficiency of Replication of the SB33 Strain and the Wild-type Strain Toulouse 1 in Human Tumor Cells

- describe experimental design
- present results of replication efficiency

## Example 2

### Comparison of the Kinetics of Diffusion of the Toulouse 1 and SG33 Viruses Expressing Beta-Galactosidase

- present results of viral diffusion

## Example 3

### Comparison of the Oncolytic Properties of the  Toulouse 1 and SG33 Viruses

- present results of oncolytic properties

